Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine 0.1% in Pediatric Allergic Conjunctivitis
NCT01109485Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olopatadine in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Mar 2010; status: completed.
02
Drugs
olopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01109485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109485.